Low-dose Dasatinib Ameliorates Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigines.

Saved in:
Bibliographic Details
Title: Low-dose Dasatinib Ameliorates Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigines.
Authors: Yi JS; Department of Pharmacology, Yale University School of Medicine, New Haven, CT, 06520, USA. jae-sung.yi@yale.edu., Perla S; Department of Pharmacology, Yale University School of Medicine, New Haven, CT, 06520, USA., Huang Y; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06520, USA., Mizuno K; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Giordano FJ; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06520, USA., Vinks AA; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; Department of Pediatrics, University of Cincinnati, College of Medicine, Cincinnati, OH, USA., Bennett AM; Department of Pharmacology, Yale University School of Medicine, New Haven, CT, 06520, USA.; Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale University School of Medicine, New Haven, CT, 06520, USA.
Source: Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2022 Aug; Vol. 36 (4), pp. 589-604. Date of Electronic Publication: 2021 Mar 10.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7241 (Electronic) Linking ISSN: 09203206 NLM ISO Abbreviation: Cardiovasc Drugs Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1573-7241
DOI:10.1007/s10557-021-07169-z